Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

An in Vitro Model of Differentiation of Memory B Cells Into Plasmablasts and Plasma Cells Including Detailed Phenotypic and Molecular Characterization.

Michel Jourdan, Anouk Caraux, John De Vos, PhD, Geneviève Fiol, Marion Larroque, Chantal Cognot, Caroline Bret, Christophe Duperray, Dirk Hose, Bernard Klein

Blood (2009) 114 (22): 1636.

https://doi.org/10.1182/blood.V114.22.1636.1636

Published: 2009

Journal Articles

Syndecan-1 Is Essential for the Myeloma Cell Growth Factor Activity of EGF-Family Ligands in Multiple Myeloma.

Karène Mahtouk, Friedrich W. Cremer, Thierry Rème, Michel Jourdan, Marion Baudard, Jérome Moreaux, Guilhem Requirand, Geneviève Fiol, John De Vos, Marion Moos, Philippe Quittet, Hartmut Goldschmidt, Jean-Francois Rossi, Dirk Hose, Bernard Klein

Blood (2005) 106 (11): 626.

https://doi.org/10.1182/blood.V106.11.626.626

Published: 2005

Journal Articles

Amphiregulin Is Produced by Myeloma Cells and Is Involved in Tumor-Environment Interactions in Multiple Myeloma.

Karène Mahtouk, Dirk Hose, Thierry Reme, John De Vos, Michel Jourdan, Jérome Moreaux, Geneviève Fiol, Marc Raab, Eric Jourdan, Marion Moos, Hartmut Goldschmidt, Jean-François Rossi, Friedrich W. Cremer, Bernard Klein

Blood (2004) 104 (11): 4306.

https://doi.org/10.1182/blood.V104.11.4306.4306

Published: 2004

Journal Articles

An inhibitor of the EGF receptor family blocks myeloma cell growth factor activity of HB-EGF and potentiates dexamethasone or anti–IL-6 antibody-induced apoptosis

Karène Mahtouk, Michel Jourdan, John De Vos, Catherine Hertogh, Geneviève Fiol, Eric Jourdan, Jean-François Rossi, Bernard Klein

Blood (2004) 103 (5): 1829–1837.

https://doi.org/10.1182/blood-2003-05-1510

Published: 2004

Journal Articles

Generation of polyclonal plasmablasts from peripheral blood B cells: a normal counterpart of malignant plasmablasts

Karin Tarte, John De Vos, Thomas Thykjaer, Fenghuang Zhan, Geneviève Fiol, Valérie Costes, Thierry Rème, Eric Legouffe, Jean-François Rossi, John Shaughnessy, Jr, Torben F. Ørntoft, Bernard Klein

Blood (2002) 100 (4): 1113–1122.

https://doi.org/10.1182/blood.V100.4.1113.h81602001113_1113_1122

Published: 2002

NARROW

An in Vitro Model of Differentiation of Memory B Cells Into Plasmablasts and Plasma Cells Including Detailed Phenotypic and Molecular Characterization.

Syndecan-1 Is Essential for the Myeloma Cell Growth Factor Activity of EGF-Family Ligands in Multiple Myeloma.

Amphiregulin Is Produced by Myeloma Cells and Is Involved in Tumor-Environment Interactions in Multiple Myeloma.

An inhibitor of the EGF receptor family blocks myeloma cell growth factor activity of HB-EGF and potentiates dexamethasone or anti–IL-6 antibody-induced apoptosis

Generation of polyclonal plasmablasts from peripheral blood B cells: a normal counterpart of malignant plasmablasts

Email alerts

ASH Publications

American Society of Hematology

An in Vitro Model of Differentiation of Memory B Cells Into Plasmablasts and Plasma Cells Including Detailed Phenotypic and Molecular Characterization.

Syndecan-1 Is Essential for the Myeloma Cell Growth Factor Activity of EGF-Family Ligands in Multiple Myeloma.

Amphiregulin Is Produced by Myeloma Cells and Is Involved in Tumor-Environment Interactions in Multiple Myeloma.

An inhibitor of the EGF receptor family blocks myeloma cell growth factor activity of HB-EGF and potentiates dexamethasone or anti–IL-6 antibody-induced apoptosis

Generation of polyclonal plasmablasts from peripheral blood B cells: a normal counterpart of malignant plasmablasts

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only